Anika Therapeutics, Inc.
$197.18M- Market cap
- $278.50M
- Debt
- +-$149.00K
- Cash
- −$81.17M
Capital structure 100% equity / -0% debt · EV / Revenue 1.75x
Quick read
Fair value engine
Each company valued on the other's multiple, then compared with the market price.
ANIK · current priceP/S 2.47x
$20.81Latest market snapshot
Implied fair value · at REXR's multiple
$68.94231.3% above market
8.43 ANIK revenue / share×8.18x REXR P/S=$68.94
Market $20.81Implied $68.94
REXR · current priceP/S 8.18x
$36.79Latest market snapshot
Implied fair value · at ANIK's multiple
$11.1169.8% below market
4.50 REXR revenue / share×2.47x ANIK P/S=$11.11
Market $36.79Implied $11.11